Clinical Trial Update: Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial investigating regorafenib for locally advanced esophageal or gastroesophageal junction cancer after chemoradiation and surgery; trial terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Esophageal Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Adenocarcinoma of the Gastroesophageal Junction, Stage IIB Esophageal Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2018-10-17